Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd., explained in plain language.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 1349 HKEX

Biopharmaceutical company developing innovative drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for deadly brain cancer? early trial launches

Disease control Not yet recruiting

This early-stage study tests a new drug called FZ-AD005 in 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to target and kill cancer cells while sparing healthy ones. The main goals are to find the…

Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:11 UTC